Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.355
-0.035 (-0.80%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $304.82 million as of August 26, 2026. Its market cap has decreased by -38.23% in one year.
Market Cap
304.82M
Enterprise Value
-190.57M
1-Year Change
-38.23%
Ranking
Category
Stock Price
$4.36
ChartMarket Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $304.82M, an increase of 43.54%. That is a compound annual growth rate of 5.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 304.82M | -37.93% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 322.27M |
| Vicore Pharma Holding AB | 314.56M |
| Cartesian Therapeutics | 304.37M |
| InflaRx | 302.10M |
| Fulcrum Therapeutics | 292.98M |
| Fate Therapeutics | 292.36M |
| Turn Therapeutics | 288.35M |
| Anavex Life Sciences | 288.21M |